SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-003141
Filing Date
2022-08-16
Accepted
2022-08-16 07:19:45
Documents
30
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2228327.htm   iXBRL 6-K 19144
2 REGISTRANT'S PRESS RELEASE DATED AUGUST 16, 2022 exhibit_1.htm EX-99 441315
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, exhibit_2.htm   iXBRL EX-99 806253
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF JUNE 30, 2022 AND FOR THE THRE exhibit_3.htm EX-99 185756
10 GRAPHIC image00001.jpg GRAPHIC 5551
  Complete submission text file 0001178913-22-003141.txt   2796849

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE blrx-20220630.xsd EX-101.SCH 27532
6 XBRL CALCULATION FILE blrx-20220630_cal.xml EX-101.CAL 30891
7 XBRL DEFINITION FILE blrx-20220630_def.xml EX-101.DEF 35459
8 XBRL LABEL FILE blrx-20220630_lab.xml EX-101.LAB 224269
9 XBRL PRESENTATION FILE blrx-20220630_pre.xml EX-101.PRE 100824
24 EXTRACTED XBRL INSTANCE DOCUMENT zk2228327_htm.xml XML 229340
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 221168474
SIC: 2834 Pharmaceutical Preparations